
Keywords: RCMκ-CN, reduced and carboxymethylated κ-casein; GS, ginsenosides; Rg1, ginsenoside Rg1; Rb1, ginsenoside Rb1; Re, ginsenoside Re; AD, Alzheimer's disease; PD, Parkinson's disease; HD, Huntington's disease; ThT, thioflavin T; RLS, resonance light scatteri